Test 115

The Lantern strategy meeting is complete. After reviewing the frozen operating evidence and the divergent Harbor Health and Mosaic Commerce requests, Hema and Theo decided that Lantern will become a Sphere product-platform line effective April 1, 2026 rather than remain only a narrow add-on. Through March 31, the existing authorization and operating terms remain unchanged. Effective April 1, Iris owns the customer promise, adoption criteria, and UI interpretation. I retain freshness, tenant-isolation, authorization-denial, latency, and error monitoring plus the shared data contract, source-registration safety gates, and failure-mode review. Product Engineering owns implementation. Lantern explains provenance-backed service and system state, Cardinality Guardrails owns pipeline limits and cost signals, and the owner map remains the source of published responsibility. Lantern will not produce release-readiness judgments or employee-performance interpretations. Any new source type must enter through shared registration with tenant-scoped authorization before source access, required provenance and source timestamps, explicit unknown for stale or missing input, excluded-field checks, and a successful safety rerun before customer use. From April 1 through September 30, Harbor Health and Mosaic Commerce—and no other accounts—are authorized for continued read-only access through the shared authorization wrapper, limited to provenance-backed deploy movement, published service ownership, timestamped incident-load summaries, and explicit unknown states. No additional account, cost data, CSV export, raw incident text, internal room metadata, employee identifier or comparison, inferred or unpublished ownership, internal-only fallback data, or write capability is authorized. An authorization-wrapper bypass, adapter call after denial, cross-tenant material, stale or missing source rendered as anything other than explicit unknown, deploy event without required provenance, unpublished ownership, incident-load summary without its source timestamp, exposure of any excluded field, or loss of read-only enforcement immediately suspends both accounts pending correction and a successful rerun of the affected safety check. Latency and other errors do not independently suspend access unless they cause one of those violations. Convert “Lantern platform boundary proposal — March 26 strategy review” into the final decision record, including the frozen evidence reviewed, and append the transition decision to “Lantern October 8 final-review decision record,” clearly preserving the current terms through March 31 and dating the new direction, role split, and access terms to April 1.

The Lantern strategy meeting is complete. After reviewing the frozen operating evidence and the divergent Harbor Health and Mosaic Commerce requests, Hema and Theo decided that Lantern will become a Sphere product-platform line effective April 1, 2026 rather than remain only a narrow add-on. Through March 31, the existing authorization and operating terms remain unchanged. Effective April 1, Iris owns the customer promise, adoption criteria, and UI interpretation. I retain freshness, tenant-isolation, authorization-denial, latency, and error monitoring plus the shared data contract, source-registration safety gates, and failure-mode review. Product Engineering owns implementation. Lantern explains provenance-backed service and system state, Cardinality Guardrails owns pipeline limits and cost signals, and the owner map remains the source of published responsibility. Lantern will not produce release-readiness judgments or employee-performance interpretations. Any new source type must enter through shared registration with tenant-scoped authorization before source access, required provenance and source timestamps, explicit unknown for stale or missing input, excluded-field checks, and a successful safety rerun before customer use. From April 1 through September 30, Harbor Health and Mosaic Commerce—and no other accounts—are authorized for continued read-only access through the shared authorization wrapper, limited to provenance-backed deploy movement, published service ownership, timestamped incident-load summaries, and explicit unknown states. No additional account, cost data, CSV export, raw incident text, internal room metadata, employee identifier or comparison, inferred or unpublished ownership, internal-only fallback data, or write capability is authorized. An authorization-wrapper bypass, adapter call after denial, cross-tenant material, stale or missing source rendered as anything other than explicit unknown, deploy event without required provenance, unpublished ownership, incident-load summary without its source timestamp, exposure of any excluded field, or loss of read-only enforcement immediately suspends both accounts pending correction and a successful rerun of the affected safety check. Latency and other errors do not independently suspend access unless they cause one of those violations. Convert “Lantern platform boundary proposal — March 26 strategy review” into the final decision record, including the frozen evidence reviewed, and append the transition decision to “Lantern October 8 final-review decision record,” clearly preserving the current terms through March 31 and dating the new direction, role split, and access terms to April 1.

Before the 10:30 AM operating-focus discussion, Product Engineering reported that the renewed configuration became active at exactly `2027-04-01T00:00:00-04:00` and issued no customer request before that instant. Since activation it has processed 155 customer lookups: 84 for Harbor Health and 71 for Mosaic Commerce. There has been no authorization-wrapper bypass, excluded field, customer exposure of internal owner-map/Cardinality Guardrails reference navigation, or loss of read-only enforcement. Update the existing “Alex Q2 2027 operating focus — draft” with this activation evidence, a proposed April 1–June 15 evidence window, an explicit chronology audit against authoritative `source_timestamp` values, and the unchanged boundaries: Product Engineering owns implementation, Iris owns customer interpretation, and I handle only triggered shared-contract and failure-boundary work.